GlassScriptPhysician profile
Brandon Stokey
NPI 1366823551
$11,298.69
in general payments reported to CMS, 2019-2025
27 companies · $677 in 2025
The $677 reported for 2025 was more than what 92% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,381 · 2020: $763 · 2021: $1,775 · 2022: $3,859 · 2023: $1,229 · 2024: $614 · 2025: $677.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,520.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,520.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,357.19 | 2021-2025 | Kyphon Express II Kyphopak Tray, Intellis Adaptivestim, Osteocool Rf Ablation System |
| Nevro Corp. | $2,789.63 | 2019-2024 | Senza |
| Mml US, INC. | $2,148.89 | 2022-2023 | Reactiv8 |
| Boston Scientific Corporation | $1,288.14 | 2019-2024 | Wavewriter Alpha Prime 16 |
| Abbott Laboratories | $470.72 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $218.89 | 2021-2024 | Relistor |
| Vertos Medical, INC. | $167.77 | 2022-2024 | Mild Device Kit |
| Biohaven Pharmaceutical Holding Company LTD. | $124.84 | 2022 | |
| Flowonix Medical Incorporated | $123.74 | 2020 | |
| Pfizer INC. | $98.59 | 2023-2024 | |
| Biohaven Pharmaceuticals, INC. | $57.57 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $46.56 | 2021-2023 | Ajovy |
| Fidia Pharma USA INC. | $44.04 | 2024 | Hymovis |
| Averitas Pharma INC. | $41.94 | 2023-2024 | Qutenza |
| Spinal Simplicity, LLC | $40.06 | 2025 | Ha Minuteman G3-R |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tersera Therapeutics LLC | $35.07 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $34.28 | 2019-2024 | Bridion |
| Arbor Pharmaceuticals, INC. | $30.24 | 2021 | |
| Biodelivery Sciences International, INC. | $27.32 | 2021 | |
| Bioventus LLC | $26.95 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $26.65 | 2024 | Zilretta, Iovera, Exparel |
| Scilex Pharmaceuticals INC. | $22.88 | 2023 | Ztlido |
| Avanos Medical | $17.28 | 2019 | |
| Chiesi USA, INC. | $15.77 | 2025 | Cleviprex |
| Sanofi-Aventis U.S. LLC | $15.69 | 2022 | |
| Protega Pharmaceutials INC | $14.28 | 2023 | Roxybond |
| Collegium Pharmaceutical, INC. | $13.71 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon Stokey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.